Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.

Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment

NCT02326857 ·Status: COMPLETED

Genetics and Heart Health After Cancer Therapy

NCT03510689 ·Status: COMPLETED

Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer

NCT07630558 ·Status: ACTIVE_NOT_RECRUITING

Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping

NCT06048458 ·Status: UNKNOWN

Proteogenomic Signatures Analysis In Ovarian Cancer

NCT05953883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

NCT02652975 ·Status: COMPLETED ·Phase: NA

Breast Cancer Proteomics and Molecular Heterogeneity

NCT01840293 ·Status: RECRUITING

Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca

NCT01074814 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Recurrence Risk Evaluation by 21-gene Detection

NCT03841266 ·Status: COMPLETED

Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients

NCT00849758 ·Status: COMPLETED

Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

NCT07582887 ·Status: RECRUITING

Breast Cancer Molecular Analysis Protocol

NCT01855503 ·Status: COMPLETED

Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients

NCT02626039 ·Status: COMPLETED

Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation

NCT05763472 ·Status: UNKNOWN

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

NCT02610426 ·Status: RECRUITING

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer

NCT05906407 ·Status: RECRUITING

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

NCT02470819 ·Status: WITHDRAWN ·Phase: NA

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

NCT03843346 ·Status: COMPLETED

A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer

NCT01919749 ·Status: COMPLETED ·Phase: NA

G8, CARG, Frailty, and Nutritional Markers in Predicting Chemotoxicity

NCT07151794 ·Status: ACTIVE_NOT_RECRUITING

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

NCT00040222 ·Status: COMPLETED

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

NCT00897299 ·Status: COMPLETED

The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma

NCT05344027 ·Status: COMPLETED

Understanding CARdiac Events in Breast Cancer

NCT05921279 ·Status: RECRUITING

Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa Rica

NCT04163159 ·Status: UNKNOWN